Literature DB >> 29104881

siRNA Screening for Genes Involved in HSV-1 Replication.

Samantha J Griffiths1, Jürgen Haas1.   

Abstract

Small interfering RNAs (siRNAs) are small (typically 18-24 nucleotides) RNA molecules capable of silencing gene expression post-transcriptionally and as such, they provide a simple method by which the role of individual genes in complex cellular systems can be easily assessed. As siRNAs are easy to use experimentally, and can be designed to target any gene (including pathogens), their use is perfectly suited to and easily adapted to high-throughput genome-wide screening methodologies and a range of phenotypic assays. Here we describe the use of a large siRNA library (>8,000 genes targeted individually) to screen for and identify host factors functionally involved in the replication of a human herpesvirus (Herpes simplex virus type 1; HSV-1) (Griffiths et al., 2013; Griffiths, 2013).

Entities:  

Year:  2014        PMID: 29104881      PMCID: PMC5669451          DOI: 10.21769/BioProtoc.1209

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  3 in total

1.  Screening for host proteins with pro- and antiviral activity using high-throughput RNAi.

Authors:  Samantha J Griffiths
Journal:  Methods Mol Biol       Date:  2013

2.  Herpes simplex virus type 1 promoter activity during latency establishment, maintenance, and reactivation in primary dorsal root neurons in vitro.

Authors:  J L Arthur; C G Scarpini; V Connor; R H Lachmann; A M Tolkovsky; S Efstathiou
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication.

Authors:  Samantha J Griffiths; Manfred Koegl; Chris Boutell; Helen L Zenner; Colin M Crump; Francesca Pica; Orland Gonzalez; Caroline C Friedel; Gerald Barry; Kim Martin; Marie H Craigon; Rui Chen; Lakshmi N Kaza; Even Fossum; John K Fazakerley; Stacey Efstathiou; Antonio Volpi; Ralf Zimmer; Peter Ghazal; Jürgen Haas
Journal:  PLoS Pathog       Date:  2013-08-08       Impact factor: 6.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.